AXSM
Axsome Therapeutics Inc
NASDAQ: AXSM · HEALTHCARE · BIOTECHNOLOGY
$207.75
+12.94% today
Updated 2026-04-30
Market cap
$9.46B
P/E ratio
—
P/S ratio
14.82x
EPS (TTM)
$-3.68
Dividend yield
—
52W range
$96 – $193
Volume
0.7M
Axsome Therapeutics Inc (AXSM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-28.70%
Operating margin
-18.40%
ROE
-252.10%
ROA
-16.80%
Debt/equity
2.96x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | — | $-2.17M | — | — | — |
| 2014 | $0.00 | $-6.00M | — | — | — |
| 2015 | $0.00 | $-12.21M | — | — | — |
| 2016 | $0.00 | $-27.20M | — | — | — |
| 2017 | $0.00 | $-28.94M | — | — | — |
| 2018 | $0.00 | $-30.97M | — | — | — |
| 2019 | $0.00 | $-68.35M | — | — | — |
| 2020 | $0.00 | $-102.90M | — | — | — |
| 2021 | $8.82M | $-134.94M | -13.10% | -1,413.95% | -1,530.01% |
| 2022 | $50.04M | $-187.13M | 89.61% | -359.33% | -373.99% |
| 2023 | $270.60M | $-239.24M | 90.37% | -85.67% | -88.41% |
| 2024 | $385.69M | $-287.22M | 91.37% | -72.74% | -74.47% |
| 2025 | $638.50M | $-183.17M | 92.56% | -26.51% | -28.69% |